Healthcare identity spans prescriber, patient and age-gated users. See how NPI/DEA checks, EPCS two-factor, and HIPAA-aligned handling fit a 2026 playbook.
Table of contents
- KYC for healthcare is not one check but several: verifying prescribers against their NPI and DEA registration, matching patients, and gating age-restricted or controlled services.
- Electronic prescribing of controlled substances is the strictest surface. The DEA's rules in 21 CFR Part 1311 require identity proofing, two-factor authentication, and digital signatures.
- NPI and DEA registration verify different things: the NPI identifies the provider, while a valid DEA registration authorises prescribing controlled substances, and you cross-reference both.
- DEA identity proofing aligns with NIST 800-63 assurance levels, and the two-factor credential must come from an approved credential service provider or certification authority.
- The architecture goal is to verify identity without the platform itself becoming a store of protected health information, which means minimising what you hold.
- Digital health platforms answer to two very different auditors, the DEA on controlled-substance prescribing and HHS Office for Civil Rights on HIPAA, so the audit trail has to satisfy both.
KYC for healthcare is the verification of the people and roles in a digital health platform: prescribers against their NPI and DEA registration, patients for record matching, and users of age-gated or controlled services. It must satisfy the DEA's electronic-prescribing rules and align with HIPAA, ideally without the platform itself becoming a store of protected health information.
TL;DR
KYC for healthcare is a multi-surface problem. Digital health platforms have to verify prescribers, match patients, and gate access to age-restricted and controlled services, and each surface has its own rules. The strictest is electronic prescribing of controlled substances, where the DEA's regulations in 21 CFR Part 1311 require identity proofing, two-factor authentication, and digital signatures before a clinician can prescribe.
The verification logic cross-references the NPI, which identifies a provider, against a valid DEA registration, which authorises controlled-substance prescribing, on top of a verified government ID and an active state licence. The architectural challenge is doing all of this without turning the platform into a honeypot of protected health information. This guide walks the four identity surfaces, the NPI-versus-DEA cross-reference, EPCS two-factor, HIPAA-aligned handling, and the audit posture the DEA and HHS Office for Civil Rights expect.
10 min read. Last updated 19 August 2026.
What does KYC for healthcare actually verify?
KYC for healthcare verifies four distinct things, and conflating them is the most common design error. The first is the prescriber: a clinician's identity, their NPI, their state licence, and their DEA registration where controlled substances are involved. The second is the patient, where the job is reliable record matching to avoid mixing records or enabling impersonation. The third is age-gated and controlled services, from controlled-substance prescribing to age-restricted telehealth, where verified age and identity gate access. The fourth is restricted-platform users, the staff and partners with access to sensitive systems.
Each surface has a different bar and a different regulator. A platform that builds one generic identity check and applies it everywhere will over-verify low-risk users and under-verify prescribers. The platform mechanics beneath these healthcare-specific rules are covered in our identity verification software comparison; the healthcare difference is which check applies to whom.
How do NPI and DEA verification differ?
The NPI and the DEA registration are often confused, and they verify different things. The National Provider Identifier is a unique administrative number that identifies a healthcare provider; it tells you who the provider is, but it does not by itself authorise prescribing controlled substances. A DEA registration is the authorisation to prescribe or handle controlled substances, tied to the provider and their location.
Robust KYC for healthcare cross-references the two: confirm the provider's identity and NPI, confirm their state licence is current, and confirm a valid DEA registration before allowing controlled-substance prescribing. A provider with a valid NPI but a lapsed or absent DEA registration should not be able to prescribe a controlled substance, and the cross-reference is what catches that. Treat the NPI as identity and the DEA registration as authorisation, and verify both rather than assuming one implies the other.
What does EPCS two-factor require under the DEA?
Electronic prescribing of controlled substances, EPCS, is the most prescriptive identity surface in healthcare, governed by the DEA in 21 CFR Part 1311. A compliant EPCS process requires three things: identity proofing of the prescriber, two-factor authentication, and a digital signature on the prescription. The identity proofing aligns with NIST 800-63 digital identity assurance levels, and it can be done in person or remotely by an approved provider.
The two-factor requirement is specific: the prescriber authenticates with two of the three recognised factors, something they know, something they have, and something they are, using a credential issued by an approved credential service provider or certification authority. A hard token or a biometric can serve as a factor, but the credential and the proofing must meet the DEA's standard, not just any consumer two-factor setup. The practical takeaway: EPCS is not satisfied by a password and an SMS code; it requires DEA-grade identity proofing and an approved two-factor credential before a controlled-substance prescription can be signed.
How do you verify identity without holding PHI?
The instinct in healthcare is to collect and store everything, which is exactly what creates HIPAA exposure. Protected health information in a central store is a breach target and a compliance liability, and identity data sitting alongside it compounds the risk. The architectural goal of KYC for healthcare is therefore to verify strongly while holding as little sensitive data as possible.
This is where a no-honeypot architecture matters. Rather than the platform accumulating identity documents and biometric data in its own cloud, a decentralised approach shards identity data across many nodes with a customer-held key, so there is no single store for an attacker to take, which is the model behind decentralised KYC and decentralised PII storage. Reusable credentials let a verified prescriber or patient re-present their verified status without the platform re-collecting and re-storing the underlying documents. Minimising what you hold is both better security and a cleaner HIPAA posture, a point we make generally in why your KYC vendor is your biggest data breach risk.
How do state laws change the requirements?
Federal rules set the floor, but US states layer their own health-data and privacy requirements on top, and a national digital health platform has to satisfy the strictest applicable. New York's SHIELD Act imposes data-security obligations on businesses holding New Yorkers' private information, Texas's medical-privacy law extends protections beyond federal HIPAA, and California maintains its own health-data and consumer-privacy framework. These shape how identity and health data must be secured, retained, and disclosed.
For KYC for healthcare the implication is that data-handling design, not just the verification check, must be state-aware: where data is stored, how long, and who can access it can all be constrained differently by state. A minimise-what-you-hold architecture is the simplest way to stay compliant across a patchwork, because the data you never stored is data no state law can fault you for mishandling. Confirm the specific obligations for the states you operate in with counsel, because the details and thresholds differ.
What audit posture do the DEA and HIPAA regulators expect?
Digital health platforms answer to two very different auditors, and the records they want differ. The DEA, on controlled-substance prescribing, expects evidence that prescribers were identity-proofed to standard, that two-factor credentials were issued and used, and that prescriptions were properly signed, with logs that reconstruct who prescribed what and how they authenticated. The HHS Office for Civil Rights, on HIPAA, expects evidence that protected health information was secured, access was controlled and logged, and breaches were handled per the rules.
The defensible posture is to make both audit trails a by-product of the system: log identity proofing and two-factor authentication for EPCS, and log access and minimise retention for HIPAA. A platform that minimises stored data has a smaller HIPAA surface to defend, and one that logs prescriber proofing cleanly satisfies the DEA. KYC for healthcare, in the end, is judged on whether you can show, per prescriber and per access, what was verified and how.
When is heavy identity verification not required in healthcare?
Not every healthcare interaction needs the EPCS-grade bar, and over-verifying is its own problem. A platform offering general wellness content, non-controlled informational services, or low-risk scheduling does not need DEA-grade identity proofing for every user, and forcing it adds friction and collects sensitive data you then have to protect.
The principle is proportionality: apply the strict prescriber and controlled-substance checks where they are legally required, and apply lighter verification where the risk and the rules are lighter. Collecting more identity and health data than a service requires is not caution, it is liability, especially under HIPAA and state privacy laws. Match the verification to the surface, verify prescribers and controlled-substance access to the DEA standard, and keep everything else proportionate and minimal. If you want help mapping which surface needs what, book a healthcare compliance walk-through.
The bottom line
KYC for healthcare is several checks wearing one name: prescriber identity and authorisation through the NPI and DEA registration, patient matching, and age-gated and controlled-service access, with electronic prescribing of controlled substances setting the strictest bar under 21 CFR Part 1311. Verify prescribers to the DEA standard with proper identity proofing and approved two-factor credentials, and cross-reference NPI against DEA registration rather than assuming one implies the other.
Then build the architecture so verification does not turn the platform into a HIPAA honeypot: minimise what you hold, use reusable credentials, and keep both the DEA and HIPAA audit trails as by-products of the system. Match the check to the surface, and the strongest compliance posture is also the leanest on data.
Get a healthcare compliance walk-through, or see how it works.
Related resources
- Identity verification software comparison 2026
- Why your KYC vendor is your biggest data breach risk
- Decentralised KYC
- Decentralised PII storage
- Proof of address verification
- KYC software
- How it works
Cited sources
- DEA Diversion Control Division, Electronic Prescriptions for Controlled Substances (EPCS) and 21 CFR Part 1311: https://www.deadiversion.usdoj.gov/faq/epcs-faq.html
- NIST Special Publication 800-63, Digital Identity Guidelines: https://pages.nist.gov/800-63-3/
- HHS Office for Civil Rights, HIPAA: https://www.hhs.gov/hipaa/index.html
- CMS, National Provider Identifier (NPI): https://www.cms.gov/regulations-and-guidance/administrative-simplification/nationalprovidentstand
- New York SHIELD Act, NY Attorney General: https://ag.ny.gov/internet/data-breach
Michelangelo Frigo (Co-Founder at Zyphe) Michelangelo Frigo is a privacy and identity infrastructure expert and co-founder of Zyphe.